AOA Dx Patents

Patent portfolio assigned to AOA Dx (verified via public assignee records). Ovarian-cancer liquid-biopsy biotech (GlycoLocate/AKRIVIS GD). has_patents=true: company's own press confirms US patent filing(s) on gangliosides as ovarian-cancer markers. Sonrai Analytics is an analytics partner (per AOA's own site). Direct-diagnostics competitors (Aspira, Mercy BioAnalytics) per CB Insights; exact patent count not visible.